Monday - January 19, 2026

Category Archives: Marketing & Sales

Infinite’s B2B Lead Generation for Food Manufacturing Drives $1.2M Pipeline for Agathangelou

“Over 12 months of working with manufacturers across North America and Europe, we tracked every conversation from initial contact to qualified opportunity. The 4,217 targeted prospects generated 71 meetings that advanced to technical specification discussions, with 17 progressing to formal … Continue reading →

Liver Cirrhosis Clinical Trials Analysis: 30+ Companies, 30+ Therapies, and 10 Key Clinical Breakthroughs Shaping the Market, analyses DelveInsight

Liver Cirrhosis Clinical Trials Prominent liver cirrhosis developers include Sagimet Biosciences, Gwo Xi Stem Cell Applied Technology, AstraZeneca, Galectin Therapeutics, Vedanta Biosciences, Resolution Therapeutics, Mirum Pharmaceuticals, TenNor Therapeutics, Prism Pharma, Ipsen, Versantis AG, Lipocine, among others. (Albany, USA) DelveInsight’s “Liver … Continue reading →

Fabry Disease Market Valued at USD 1.7 Billion in 2024, According to DelveInsight

Fabry Disease Market Key companies active in the Fabry Disease space include Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, 4D Molecular Therapeutics, Idorsia Pharmaceuticals, GREENOVATION BIOTECH GMBH, Shire, Takeda, Amicus Therapeutics, Protalix, uniQure, Codexis, MP6 Therapeutics, and CellGenTech. DelveInsight … Continue reading →

Congenital Adrenal Hyperplasia Pipeline 2025: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight| Becton, Dickinson and Company, Cook Medical, Cooper Surgical, Smiths Medi

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Congenital Adrenal Hyperplasia pipeline constitutes 5+ key companies continuously working towards developing 8+ Congenital Adrenal Hyperplasia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Acute Pancreatitis Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Dynavax Tech, Fresenius SE, GlaxoSmithKline, Abbott, B. Braun SE

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acute Pancreatitis pipeline constitutes 4+ key companies continuously working towards developing 4+ Acute Pancreatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Spinal Muscular Atrophy Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Genentech Inc, Chugai Pharma, Cytokinetics Inc., Ionis Pharma, Genzyme

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Spinal Muscular Atrophy pipeline constitutes 18+ key companies continuously working towards developing 20+ Spinal Muscular Atrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Atopic Dermatitis Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | GlaxoSmithKline PLC, Nestle SA, Pfizer Inc., Regeneron Pharma, Abbvie, Allergan

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 120+ Atopic Dermatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →